Christopher Bavitz joined General Counsels from some of America’s health care institutions – hospitals, insurers, biotechnology companies – at Harvard Law School as part of the General Counsels Roundtable to explore pressing health policy and legal issues facing companies today.
Bavitz led the group in a discussion of the opportunities and challenges that artificial intelligence, machine learning, and algorithms present to the health care industry. The spirited conversation that followed raised questions on how to conceptualize the role of AI in health care decisions. Should AI be used as tool, or decision-maker? Or should it be viewed as a product or service, or even in some sense a “hire” for the system?